Tag: Fda advisory

In November 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory recommending against the use of products containing phenylpropanolamine (PPA) due to an increased risk of hemorrhagic stroke. Before its recall, many asked, **what is PPA Syrup used for?**, as it was commonly found in over-the-counter cold medicines and appetite suppressants.

In a unanimous 2023 decision, an FDA advisory panel concluded that oral phenylephrine, the active ingredient in Sudafed PE, is ineffective as a nasal decongestant at its recommended dosage. This has led many to question: what does Sudafed PE actually do, and why has it been so widely available if it doesn't work?

In the early 2000s, dozens of case reports linking kava-containing products to severe liver injury, including hepatitis and liver failure, led multiple countries to remove the popular herbal supplement from the market. This widespread regulatory action was a direct response to a growing public health concern about why was kava taken off the market.

In 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory recommending against the use of products containing the active ingredient found in Rinexin, citing an increased risk of hemorrhagic stroke. This advisory significantly changed the use and availability of Rinexin and its key component, phenylpropanolamine, which was previously used to treat congestion and aid in weight loss.

In 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory concerning products containing phenylpropanolamine (PPA), the primary active ingredient formerly used in the medication known as sinudrin. As a result, the drug sinudrin was primarily used as a nasal decongestant but is no longer available in many countries due to serious safety concerns. This guide explores its historical application, the reasons for its removal from the market, and modern alternatives for nasal congestion.

In September 2023, an FDA advisory panel unanimously concluded that oral phenylephrine, which is **fenilefrina** in English, is ineffective as a nasal decongestant. This decision put the spotlight on a common over-the-counter medication and its surprisingly poor performance in pill form.